Currently, the MET-AD phase III clinical trial is rigorously evaluating its impact on the progression of AD
HbA1c drops, fasting glucose drops, triglycerides drop, and LDL often drops too
Its glucose-lowering action is particularly useful for patients with insulin resistance or pre-diabetes alongside excess weight, because improving insulin sensitivity changes how the body stores and mobilizes fat
Through this process, fresher and brighter skin emerges with reduced melanin content
This advanced formula combines 5 powerful bioactives to combat hyperpigmentation, protect against UV damage, and promote brighter, smoother skin
Aim for 1.2-1.6g protein per kg body weight This range helps preserve muscle mass during weight loss, especially important with GLP-1 therapy